AGP Picks
View all

AGP Executive Report

Last update: 10 hours ago

Medical Access & Rights: Guinea-Bissau’s military government has allowed opposition leader Domingos Simões Pereira to leave prison and travel to Portugal for medical treatment, after a court decision cited health needs; his release is described as conditional and set to be reviewed when a 90-day medical leave ends, amid ongoing political tensions and ECOWAS calls for the unconditional release of detained figures. Public Health & Climate: A new Nature study finds climate change is slightly increasing malaria overall in sub-Saharan Africa’s children, with future risk rising in southern and East Africa while easing in today’s hottest hotspots—important context for West African health planning. Water & Health Services: Data cited by UN-Water/Our World in Data shows Guinea-Bissau has about 24% access to safely managed drinking water, highlighting major gaps in safe water that directly affect child and maternal health. Environment & Community Resilience: Wetlands International launched Mangrove Capital Africa Phase IV in Freetown, targeting mangrove restoration along Senegal–Guinea-Bissau–Sierra Leone coastal corridors to support livelihoods and resilience for communities facing climate pressures.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

No AGP Wire articles available right now.


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
World Reuters Guinea-Bissau's imprisoned opposition leader allowed to travel for medical treatment

World Reuters Guinea-Bissau's imprisoned opposition leader allowed to travel for medical treatment


fallback image
Feb. 22, 2026

Guinea-Bissau Stops Trump-Backed Hepatitis B Vaccine Study

MENAFN

fallback image
Feb. 22, 2026

Guinea-Bissau Stops US-Funded Hepatitis B Vaccine Trial

MENAFN

fallback image
Feb. 25, 2026

STAND UP FOR SCIENCE: CDC-FUNDED HEPATITIS B STUDY IN GUINEA-BISSAU CANCELLED

EIN Presswire

fallback image
Feb. 17, 2026

STAND UP FOR SCIENCE CONDEMNS U.S.-FUNDED HEPATITIS B STUDY IN GUINEA-BISSAU

EIN Presswire

fallback image
Jan. 13, 2026

SOMAÍ and Universidade Lusófona Publish Peer-Reviewed Study Validating Full-Spectrum Oil Consistency

EIN Presswire

More press releases

Video Stories

YouTube video thumbnail: Explainer: Surrogacy Laws and Rules Vary Widely Across Africa
Play
Explainer: Surrogacy Laws and Rules Vary Widely Across Africa
YouTube video thumbnail: Ghana's Government Backs Extending Presidential Term From Four to Five Years
Play
Ghana's Government Backs Extending Presidential Term From Four to Five Years
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: Amnesty Calls for war Crimes Probe After Killing of at Least 19 Malian Soldiers
Play
Amnesty Calls for war Crimes Probe After Killing of at Least 19 Malian Soldiers
YouTube video thumbnail: Congo Struggles to Contain Fastest-Ever Ebola Outbreak, as Death Toll Passes 1,500
Play
Congo Struggles to Contain Fastest-Ever Ebola Outbreak, as Death Toll Passes 1,500

Video Title

Sign up for:

Guinea Bissau Health Bulletin

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Guinea Bissau Health Bulletin

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.